Competitive dopamine receptor antagonists increase the equiactive cocaine concentration during self-administration

Synapse

Volumn 65, Issue 5, 2011, Pages 404-411

  Norman, Andrew B ^a   Norman, Mantana K ^a   Tabet, Michael R ^a   Tsibulsky, Vladimir L ^a   Pesce, Amadeo J ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Compulsion zone; D1 dopamine receptor; D2 dopamine receptor; Equiactive agonist concentration; Eticlopride; Pharmacodynamics; Pharmacokinetics; Satiety threshold; SCH23390

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COCAINE; ETICLOPRIDE;

ACCELERATION; ANIMAL EXPERIMENT; ARTICLE; CONTINUOUS INFUSION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SELF ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SATIETY; STEADY STATE;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BENZAZEPINES; COCAINE; CONDITIONING, OPERANT; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; DRUG INTERACTIONS; MALE; RATS; RATS, SPRAGUE-DAWLEY; SALICYLAMIDES; SELF ADMINISTRATION; TIME FACTORS;

EID: 79952208078     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20858     Document Type: Article

References (30)

1. Barrett AC, Miller JR, Dohrmann JM, Caine SB. 2004. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats. Neuropharmacology 47: 256-273.
2. Benuck M, Lajtha A, Reith MEA. 1987. Pharmacokinetics of systemically administered cocaine and locomotor stimulation in mice. J Pharmacol Exp Ther 243: 144-149.
3. Booze RM, Lehner AF, Wallace DR, Welch MA, Mactutus CF. 1997. Dose-response cocaine pharmacokinetics and metabolite profile following intravenous administration and arterial sampling in unanesthetized, freely moving male rats. Neurotoxicol Teratol 19: 7-15.
4. Britton DR, Curzon P, Mackenzie RG, Kebabian JW, Williams JEG, Kerkman D. 1991. Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration. Pharmacol Biochem Behav 39: 911-915.
5. Caine SB, Koob GF. 1994. Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther 270: 209-218.
6. Colqhoun D. 2007. Why the Schild method is better than Schild realised. Trends Pharmacol Sci 28: 608-614.
7. Cone EJ, Risner ME, Niedert GL. 1978. Concentrations of phenethylamine in dog following single doses and during intravenous self-administration. Res Commun Chem Pathol Pharmacol 22: 211-232.
8. Corrigall WA, Coen KM. 1991. Cocaine self-administration is increased by both D1 and D2 dopamine antagonists. Pharmacol Biochem Behav 39: 799-802.
9. Evans SM, Foltin RW. 2004. Pharmacokinetics of intravenous cocaine across the menstrual cycle in rhesus monkeys. Neuropsychopharmacology 29: 1889-1900.
10. Gerber GJ, Wise RA. 1989. Pharmacological regulation of intravenous cocaine and heroin self-administration in rats: A variable dose paradigm. Pharmacol Biochem Behav 32: 527-531.
11. Harris DS, Everhart ET, Mendelson J, Jones RT. 2003. The pharmacology of cocaethylene in humans following cocaine and ethanol administration. Drug Alchohol Depend 72: 169-182.
12. Hietala J, Seppala T, Lappalainen J, Syvalahti E. 1992. Quantification of SCH 39166, a novel D1 dopamine receptor antagonist, in rat brain and blood. Psychopharmacology 106: 455-458.
13. Hubner CB, Moreton JE. 1991. Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat. Psychopharmacology 105: 151-156.
14. 1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat. Neurosci Lett 79: 315-320.
15. Lau CE, Sun L. 2002. The pharmacokinetic determinants of the frequency and pattern of intravenous cocaine self-administration in rats by pharmacokinetic modeling. Drug Metab Dispos 30: 254-261.
16. Mello NK, Negus SS. 1996. Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14: 375-424.
17. Misra AL, Giri VV, Patel MN, Alluri VR, Mule SJ. 1977. Disposition and metabolism of [3H] cocaine in acutely and chronically treated monkeys. Drug Alcohol Depend 2: 261-272.
18. Norman AB, Tsibulsky VL. 2006. The compulsion zone: A pharmacological theory of acquired cocaine self-administration. Brain Res 1116: 143-152.
19. Norman AB, Norman MK, Hall JF, Tsibulsky VL. 1999. Priming threshold: A novel quantitative measure of the reinstatement of cocaine self-administration. Brain Res 831: 165-174.
20. Norman AB, Tabet MR, Norman MK, Buesing WR, Pesce AJ, Ball WJ. 2007. A chimeric human/murine anticocaine monoclonal antibody inhibits the distribution of cocaine to the brain in mice. J Pharmacol Exp Ther 320: 145-153.
21. Rang HP. 2006. The receptor concept: Pharmacology's big idea. Br J Pharmacol 147: S9-S16.
22. Roberts DCS, Vickers G. 1984. Atypical neuroleptics increase self-administration of cocaine: An evaluation of a behavioral screen for antipsychotic activity. Psychopharmacology 82: 135-139.
23. Schild HO. 1957. Drug antagonism and pAx. Pharmacol Rev 9: 242-246.
24. Tsibulsky VL, Norman AB. 1999. Satiety threshold: A quantitative model of maintained cocaine self-administration. Brain Res 839: 85-93.
25. Warner A, Norman AB. 2000. Mechanisms of cocaine hydrolysis and metabolism in vitro and in vivo: A clarification. Ther Drug Monit 22: 266-270.
26. Wise RA. 1987. Intravenous self-administration: A special case of positive reinforcement. In: Bozarth MA, editor. Methods of assessing the reinforcing properties of abused drugs. New York: Springer-Verlag. p 117-141.
27. Wise RA. 1999. Cognitive factors in addiction and nucleus accumbens function: Some hints from rodent models. Psychobiology 27: 300-310.
28. Wise RA, Newton P, Leeb K, Burnette B, Pocock D, Justice JB. 1995. Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats. Psychopharmacology 120: 10-20.
29. Yokel RA, Pickens R. 1974. Drug level of D- and L-amphetamine during intravenous self-administration. Psychopharmacologia 34: 255-264.
30. Yokel RA, Wise RA. 1975. Increased lever pressing for amphetamine after pimozide in rats: Implications for a dopamine theory of reward. Science 187: 547-549.